Literature DB >> 31736489

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.

Yi Chen1, Curt Mazur2, Yi Luo1, Linhong Sun1, Mingdi Zhang1, Alex McCampbell1, Giulio Srubek Tomassy3.   

Abstract

The blood brain barrier (BBB) is an important defense against the entrance of potentially toxic or pathogenic agents from the blood into the central nervous system (CNS). However, its existence also dramatically lowers the accessibility of systemically administered therapeutic agents to the CNS. One method to overcome this, is to inject those agents directly into the cerebrospinal fluid (CSF), thus bypassing the BBB. This can be done via implantation of a catheter for either continuous infusion using an osmotic pump, or for single bolus delivery. In this article, we describe a surgical protocol for delivery of CNS-targeting antisense oligonucleotides (ASOs) via a catheter implanted directly into the cauda equina space of the adult rat spine. As representative results, we show the efficacy of a single bolus ASO intrathecal (IT) injection via this catheterization system in knocking down the target RNA in different regions of the rat CNS. The procedure is safe, effective and does not require expensive equipment or surgical tools. The technique described here can be adapted to deliver drugs in other modalities as well.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31736489     DOI: 10.3791/60274

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Population pharmacokinetic modeling of CSF to blood clearance: prospective tracer study of 161 patients under work-up for CSF disorders.

Authors:  Markus Herberg Hovd; Espen Mariussen; Hilde Uggerud; Aslan Lashkarivand; Hege Christensen; Geir Ringstad; Per Kristian Eide
Journal:  Fluids Barriers CNS       Date:  2022-07-01

2.  Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood.

Authors:  Per K Eide; Espen Mariussen; Hilde Uggerud; Are H Pripp; Aslan Lashkarivand; Bjørnar Hassel; Hege Christensen; Markus Herberg Hovd; Geir Ringstad
Journal:  JCI Insight       Date:  2021-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.